Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer"
written by Susan Tsai, Kathleen K. Christians, Ben George, Paul Ritch, Kiyoko Oshima, Parag Tolat, Ashley Krepline, Beth A. Erickson, Douglas B. Evans,
published by Journal of Cancer Therapy, Vol.7 No.1, 2016

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Intraoperative Radiotherapy (IORT)–A New Frontier for Personalized Medicine as Adjuvant Treatment and Treatment of Locally Recurrent Advanced …
	2019

[2]	Intraoperative Radiation “Boost” to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A …
	2018

[3]	Intraoperative Radiation “Boost” to the surgical Resection Bed following pancreaticoduodenectomy for a Borderline Resectable pancreatic Carcinoma: a Case …
	Frontiers in Oncology, 2018

[4]	Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs.
	Journal of Gastrointestinal Surgery, 2017

[5]	Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs
	Journal of Gastrointestinal Surgery, 2017

[6]	Kan behandling med neoadjuvant kjemoterapi øke overlevelse og resektabilitet ved pankreaskreft sammenlignet med kirurgi etterfulgt av adjuvant kjemoterapi?
	2017

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies